person · Reporting owner
Rudelius Robert James
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PetVivo Holdings, Inc.PETV · Entity 7591 | Director | September 18, 2026 | September 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PetVivo Holdings, Inc.
Report date September 18, 2026 · Filed September 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 406,889 |
Ending reported balance
After 2026-09-18 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-18 · Grant · Acquired 2,000 · Balance 405,392 F1: Represents the acquisition by the Reporting Person of 2,000 shares and 1,497 shares of PetVivo Holdings, Inc. common stock, for an aggregate of 3,497 shares, through open-market transactions. Row 2 · 2026-09-18 · Grant · Acquired 1,497 · Balance 406,889 F1: Represents the acquisition by the Reporting Person of 2,000 shares and 1,497 shares of PetVivo Holdings, Inc. common stock, for an aggregate of 3,497 shares, through open-market transactions. |
| Common StockSEC Table I · non-derivative | IndirectBy corporation | 21,000 |
Reported balance
Holding disclosure · report date 2026-09-18 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 21,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the acquisition by the Reporting Person of 2,000 shares and 1,497 shares of PetVivo Holdings, Inc. common stock, for an aggregate of 3,497 shares, through open-market transactions.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Axogen, Inc.
Report date September 30, 2020 · Filed October 01, 2020
Section 16 reporting ended · disclosed 2020-10-01. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 18, 2026 Filed Sep 21, 2026 19:33 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock | 1,497 | $0.75 | $1,122.75 |
DisclosureSEC source: 0001493152-26-043551 · ownership.xml · nonDerivative · entry 2 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 406,889 F1 · shares: Represents the acquisition by the Reporting Person of 2,000 shares and 1,497 shares of PetVivo Holdings, Inc. common stock, for an aggregate of 3,497 shares, through open-market transactions. Read SEC document |
| September 18, 2026 Filed Sep 21, 2026 19:33 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock | 2,000 | $0.72 | $1,440.00 |
DisclosureSEC source: 0001493152-26-043551 · ownership.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 405,392 F1 · shares: Represents the acquisition by the Reporting Person of 2,000 shares and 1,497 shares of PetVivo Holdings, Inc. common stock, for an aggregate of 3,497 shares, through open-market transactions. Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 20:22 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock | 50,000 | $0.40 | $20,000.00 |
DisclosureSEC source: 0001493152-26-017871 · ownership.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 403,392 F1 · shares: Represents a purchase of 50,000 shares of PetVivo Holdings, Inc. restricted common stock ("Shares") by the Reporting Person in a private sale from another shareholder of PetVivo Holdings, Inc. Read SEC document |
| March 09, 2026 Filed Mar 24, 2026 01:01 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock | 35,000 | $0.74 | $25,900.00 |
DisclosureSEC source: 0001493152-26-012233 · ownership.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 353,392 F1 · shares: Represents an aggregate one-time grant of 35,000 shares of PetVivo Holdings, Inc. restricted common stock ("Shares") to the Reporting Person as compensation for prior Board service. Read SEC document |
| November 24, 2025 Filed Nov 25, 2025 11:12 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock | 500 | $1.28 | $640.00 |
DisclosureSEC source: 0001493152-25-024900 · ownership.xml · nonDerivative · entry 3 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 318,392 F1 · shares: The reported transactions reflect the open-market purchase of 3,000, 523 and 500 shares, respectively, of the Issuer's common stock by the reporting person. The purchases were made in routine investment transactions and not pursuant to any compensatory or issuer-sponsored plan. Read SEC document |
| November 24, 2025 Filed Nov 25, 2025 11:12 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock | 523 | $1.05 | $549.15 |
DisclosureSEC source: 0001493152-25-024900 · ownership.xml · nonDerivative · entry 2 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,892 F1 · shares: The reported transactions reflect the open-market purchase of 3,000, 523 and 500 shares, respectively, of the Issuer's common stock by the reporting person. The purchases were made in routine investment transactions and not pursuant to any compensatory or issuer-sponsored plan. Read SEC document |
| November 24, 2025 Filed Nov 25, 2025 11:12 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock | 3,000 | $1.08 | $3,240.00 |
DisclosureSEC source: 0001493152-25-024900 · ownership.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,369 F1 · shares: The reported transactions reflect the open-market purchase of 3,000, 523 and 500 shares, respectively, of the Issuer's common stock by the reporting person. The purchases were made in routine investment transactions and not pursuant to any compensatory or issuer-sponsored plan. Read SEC document |
| October 10, 2025 Filed Oct 17, 2025 17:33 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock | 12,500 | $1.28 | $16,000.00 |
DisclosureSEC source: 0001493152-25-018415 · ownership.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314,369 F1 · shares: Represents an aggregate annual grant of 50,000 shares of PetVivo Holdings, Inc. restricted common stock ("Shares") to the Reporting Person as compensation for Board service, which vests in four equal amounts at the rate of 12,500 Shares at the beginning of each quarter of Board service. Read SEC document |
| March 31, 2025 Filed Aug 11, 2025 10:15 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock | 15,589 | $0.60 | $9,353.40 |
DisclosureSEC source: 0001641172-25-022882 · ownership.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 301,869 F1 · shares: Represents a grant of shares of PetVivo Holdings, Inc. restricted common stock ("Shares") to the Reporting Person as compensation for the purchase and relinquishment of Non-Qualified Stock Options held by the Reporting Person. Read SEC document |
| October 30, 2024 Filed Nov 25, 2024 15:35 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock | 100,000 | $0.50 | $50,000.00 |
DisclosureSEC source: 0001493152-24-047567 · ownership.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 286,280 Read SEC document |
| October 16, 2024 Filed Oct 19, 2024 01:30 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock | 35,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-24-041678 · ownership.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,280 F1 · shares: Represents a grant of shares of PetVivo Holdings, Inc. restricted common stock ("Shares") to the Reporting Person as compensation for Board service, which vests in four equal amounts at the rate of 8,750 Shares at the beginning of each quarter of Board service. F1 · price: Represents a grant of shares of PetVivo Holdings, Inc. restricted common stock ("Shares") to the Reporting Person as compensation for Board service, which vests in four equal amounts at the rate of 8,750 Shares at the beginning of each quarter of Board service. Read SEC document |
| October 16, 2024 Filed Nov 18, 2024 11:08 UTC Amendment | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock | 35,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-24-046409 · ownership.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,280 F1 · shares: Represents a grant of shares of PetVivo Holdings, Inc. restricted common stock ("Shares") to the Reporting Person as compensation for Board service, which vests in four equal amounts at the rate of 8,750 Shares at the beginning of each quarter of Board service. F1 · price: Represents a grant of shares of PetVivo Holdings, Inc. restricted common stock ("Shares") to the Reporting Person as compensation for Board service, which vests in four equal amounts at the rate of 8,750 Shares at the beginning of each quarter of Board service. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 02:07 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantStock Option (right to buy) · Derivative | 31,780 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0001493152-24-000173 · ownership.xml · derivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,780 Underlying: Common Stock · 31,780 shares Expires 2030-12-28 F1 · derivative.exercise_date: The Options were granted under the PetVivo Holdings, Inc. Amended and Restated 2020 Equity Incentive Plan and vest on the earlier of (i) September 30, 2024, or (ii) the day immediately preceding the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a director through the vesting date. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 19:03 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | PurchaseCommon Stock | 860 | $2.65 | $2,279.00 |
DisclosureSEC source: 0001493152-22-033286 · ownership.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,611 Read SEC document |
| November 18, 2022 Filed Nov 21, 2022 19:45 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | PurchaseCommon Stock | 400 | $2.60 | $1,040.00 |
DisclosureSEC source: 0001493152-22-033082 · ownership.xml · nonDerivative · entry 2 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,751 Read SEC document |
| November 18, 2022 Filed Nov 21, 2022 19:45 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | PurchaseCommon Stock | 1,240 | $2.55 | $3,162.00 |
DisclosureSEC source: 0001493152-22-033082 · ownership.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,351 Read SEC document |
| October 21, 2022 Filed Oct 24, 2022 21:20 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantStock Option (right to buy) · Derivative | 23,835 | $0.00 Strike: $2.56 | $0.00 |
DisclosureSEC source: 0001493152-22-029441 · ownership.xml · derivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,835 Underlying: Common Stock · 23,835 shares Expires 2029-10-20 F1 · derivative.exercise_date: The Options were granted under the PetVivo Holdings, Inc. Amended and Restated 2020 Equity Incentive Plan and vest on the earlier of (i) September 30, 2023 or (ii) the day immediately preceding the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a director through the vesting date. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 18:46 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | ConversionCommon Stock Warrant · Derivative | 1,875 | Not disclosed Strike: $1.60 | Not disclosed |
DisclosureSEC source: 0001493152-22-018499 · ownership.xml · derivative · entry 8 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,668 Underlying: Common Stock · 1,875 shares Expires 2025-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Robert Rudelius converted 19,687, 1,434, 1,451 and 1,875 warrants for common stock with exercise prices of $1.33, $1.95, $1.60, and $1.60 per share, respectively, into 24,447 shares of common stock by transmitting a payment to the Company in a total amount of $34,369.84. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 18:46 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | ConversionCommon Stock Warrant · Derivative | 1,451 | Not disclosed Strike: $1.60 | Not disclosed |
DisclosureSEC source: 0001493152-22-018499 · ownership.xml · derivative · entry 7 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,543 Underlying: Common Stock · 1,451 shares Expires 2025-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Robert Rudelius converted 19,687, 1,434, 1,451 and 1,875 warrants for common stock with exercise prices of $1.33, $1.95, $1.60, and $1.60 per share, respectively, into 24,447 shares of common stock by transmitting a payment to the Company in a total amount of $34,369.84. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 18:46 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | ConversionCommon Stock Warrant · Derivative | 1,434 | Not disclosed Strike: $1.95 | Not disclosed |
DisclosureSEC source: 0001493152-22-018499 · ownership.xml · derivative · entry 6 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,994 Underlying: Common Stock · 1,434 shares Expires 2024-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Robert Rudelius converted 19,687, 1,434, 1,451 and 1,875 warrants for common stock with exercise prices of $1.33, $1.95, $1.60, and $1.60 per share, respectively, into 24,447 shares of common stock by transmitting a payment to the Company in a total amount of $34,369.84. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 18:46 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | ConversionCommon Stock Warrant · Derivative | 19,687 | Not disclosed Strike: $1.33 | Not disclosed |
DisclosureSEC source: 0001493152-22-018499 · ownership.xml · derivative · entry 5 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,428 Underlying: Common Stock · 19,687 shares Expires 2023-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Robert Rudelius converted 19,687, 1,434, 1,451 and 1,875 warrants for common stock with exercise prices of $1.33, $1.95, $1.60, and $1.60 per share, respectively, into 24,447 shares of common stock by transmitting a payment to the Company in a total amount of $34,369.84. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 18:46 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | Exercise / conversionCommon Stock | 1,875 | $1.60 | $3,000.00 |
DisclosureSEC source: 0001493152-22-018499 · ownership.xml · nonDerivative · entry 4 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,111 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 18:46 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | Exercise / conversionCommon Stock | 1,451 | $1.60 | $2,321.60 |
DisclosureSEC source: 0001493152-22-018499 · ownership.xml · nonDerivative · entry 3 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 18:46 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | Exercise / conversionCommon Stock | 1,434 | $1.95 | $2,796.30 |
DisclosureSEC source: 0001493152-22-018499 · ownership.xml · nonDerivative · entry 2 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,785 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 18:46 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | Exercise / conversionCommon Stock | 19,687 | $1.33 | $26,183.71 |
DisclosureSEC source: 0001493152-22-018499 · ownership.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,351 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2022 Filed May 4, 2022 13:15 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantEmployee Stock Option (right to buy) · Derivative | 6,740 | $0.00 Strike: $2.04 | $0.00 |
DisclosureSEC source: 0001493152-22-012033 · ownership.xml · derivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,740 Underlying: Common Stock · 6,740 shares Expires 2027-05-02 F1 · derivative.exercise_date: The Options were granted under the PetVivo Holdings, Inc. 2020 Equity Incentive Plan and are fully vested on the grant date. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 19:25 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock | 8,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-024487 · ownership.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,997 F1 · kind: These shares will vest and be issued with respect to 4,167 shares on October 1, 2021 and 4,166 shares will vest on March 31, 2022, pursuant to restricted stock units granted to the Reporting Person for Board services pursuant to the PetVivo Holdings, Inc. 2020 Equity Incentive Plan ("2020 Plan"). F1 · shares: These shares will vest and be issued with respect to 4,167 shares on October 1, 2021 and 4,166 shares will vest on March 31, 2022, pursuant to restricted stock units granted to the Reporting Person for Board services pursuant to the PetVivo Holdings, Inc. 2020 Equity Incentive Plan ("2020 Plan"). F2 · balance_after: Includes 8,333 shares that will be issued over time subject to vesting pursuant to the restricted stock units granted under the 2020 Plan. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 18:41 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | Exercise / conversionWarrants · Derivative | 1,594 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001493152-21-021990 · ownership.xml · derivative · entry 2 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,594 shares Expires 2025-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 18:41 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | Exercise / conversionCommon Stock | 1,594 | $1.27 | $2,030.76 |
DisclosureSEC source: 0001493152-21-021990 · ownership.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2020 Filed Sep 22, 2020 17:50 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock | 42,509 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-20-018145 · ownership.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 537,363 F1 · price: The Company's Board of Directors granted Robert Rudelius 42,509 shares of restricted stock for exemplary work performed on behalf of the Company. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 21:37 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantCommon Stock | 2,591 | $11.75 | $30,444.25 |
DisclosureSEC source: 0001179110-20-009635 · edgar.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,183 F1 · shares: This reflects the number of restricted stock units that became vested as of September 3, 2020. Read SEC document |
| July 01, 2020 Filed Sep 11, 2020 12:11 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock Warrant · Derivative | 7,500 | Not disclosed Strike: $0.40 | Not disclosed |
DisclosureSEC source: 0001493152-20-017597 · ownership.xml · derivative · entry 2 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,915 Underlying: Common Stock · 7,500 shares Expires 2025-07-01 F2 · price: The Board of Directors awarded Robert Rudelius 7,500 warrants for service on the Board of Directors between July 1, 2020 and August 31, 2020. Read SEC document |
| June 30, 2020 Filed Sep 11, 2020 12:11 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock Warrant · Derivative | 5,804 | Not disclosed Strike: $0.40 | Not disclosed |
DisclosureSEC source: 0001493152-20-017597 · ownership.xml · derivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,415 Underlying: Common Stock · 5,804 shares Expires 2025-06-30 F1 · price: The Board of Directors awarded Robert Rudelius 5,804 warrants for various committee services. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:59 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantRestricted Stock Units · Derivative | 4,115 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-006906 · edgar.xml · derivative · entry 2 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,115 Underlying: Common Stock · 4,115 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. F1 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2021, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units. F1 · derivative.expiration_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2021, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:59 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantStock Option (right to purchase) · Derivative | 16,807 | $0.00 Strike: $9.72 | $0.00 |
DisclosureSEC source: 0001179110-20-006906 · edgar.xml · derivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,807 Underlying: Common Stock · 16,807 shares Expires 2030-06-01 F1 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2021, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units. Read SEC document |
| June 01, 2020 Filed Jun 12, 2020 20:24 UTC Amendment | Axogen, Inc. AXGN · Entity 4297 | GrantRestricted Stock Units · Derivative | 6,173 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-007285 · edgar.xml · derivative · entry 2 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,173 Underlying: Common Stock · 6,173 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. F3 · shares: The original Form 4, filed June 3, 2020, incorrectly stated the number of derivative securities (Column 5), the number of shares (Column 7) and number of derivatives securities beneficially owned following reported transaction (Column 9) for both the Stock Options and Restricted Stock Units. Footnote 1 has also been amended to reflect the accurate number of stock options and restricted stock units. F1 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2021, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and One-half of the annual equity grant value is in the form of restricted stock units. F1 · derivative.expiration_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2021, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and One-half of the annual equity grant value is in the form of restricted stock units. F3 · derivative.underlying_shares: The original Form 4, filed June 3, 2020, incorrectly stated the number of derivative securities (Column 5), the number of shares (Column 7) and number of derivatives securities beneficially owned following reported transaction (Column 9) for both the Stock Options and Restricted Stock Units. Footnote 1 has also been amended to reflect the accurate number of stock options and restricted stock units. F3 · balance_after: The original Form 4, filed June 3, 2020, incorrectly stated the number of derivative securities (Column 5), the number of shares (Column 7) and number of derivatives securities beneficially owned following reported transaction (Column 9) for both the Stock Options and Restricted Stock Units. Footnote 1 has also been amended to reflect the accurate number of stock options and restricted stock units. Read SEC document |
| June 01, 2020 Filed Jun 12, 2020 20:24 UTC Amendment | Axogen, Inc. AXGN · Entity 4297 | GrantStock Option (right to purchase) · Derivative | 12,605 | $0.00 Strike: $9.72 | $0.00 |
DisclosureSEC source: 0001179110-20-007285 · edgar.xml · derivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,605 Underlying: Common Stock · 12,605 shares Expires 2030-06-01 F3 · shares: The original Form 4, filed June 3, 2020, incorrectly stated the number of derivative securities (Column 5), the number of shares (Column 7) and number of derivatives securities beneficially owned following reported transaction (Column 9) for both the Stock Options and Restricted Stock Units. Footnote 1 has also been amended to reflect the accurate number of stock options and restricted stock units. F1 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2021, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and One-half of the annual equity grant value is in the form of restricted stock units. F3 · derivative.underlying_shares: The original Form 4, filed June 3, 2020, incorrectly stated the number of derivative securities (Column 5), the number of shares (Column 7) and number of derivatives securities beneficially owned following reported transaction (Column 9) for both the Stock Options and Restricted Stock Units. Footnote 1 has also been amended to reflect the accurate number of stock options and restricted stock units. F3 · balance_after: The original Form 4, filed June 3, 2020, incorrectly stated the number of derivative securities (Column 5), the number of shares (Column 7) and number of derivatives securities beneficially owned following reported transaction (Column 9) for both the Stock Options and Restricted Stock Units. Footnote 1 has also been amended to reflect the accurate number of stock options and restricted stock units. Read SEC document |
| March 31, 2020 Filed Jun 1, 2020 22:24 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock Warrant · Derivative | 6,376 | Not disclosed Strike: $0.32 | Not disclosed |
DisclosureSEC source: 0001493152-20-010302 · ownership.xml · derivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,611 Underlying: Common Stock · 6,376 shares Expires 2025-03-31 F1 · price: The Board of Directors awarded Robert Rudelius 6,376 warrants for various committee services. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 13:03 UTC | Axogen, Inc. AXGN · Entity 4297 | Exercise / conversionDirector Stock Option (right to purchase) · Derivative | 13,000 | $0.00 Strike: $2.75 | $0.00 |
DisclosureSEC source: 0001179110-20-000065 · edgar.xml · derivative · entry 3 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,000 shares Expires 2020-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 13:03 UTC | Axogen, Inc. AXGN · Entity 4297 | Tax withholdingCommon Stock | 1,999 | $17.89 | $35,762.11 |
DisclosureSEC source: 0001179110-20-000065 · edgar.xml · nonDerivative · entry 2 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,592 F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 13,000 shares by means of a cashless exercise. A cashless exercise is a method of exercising a stock option in which the option holder pays the exercise price using shares the reporting person would have received pursuant to the option exercise. As a result of this cashless exercise, the Reporting Person, on a net basis, acquired ownership of an additional 11,001 shares of common stock. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 13:03 UTC | Axogen, Inc. AXGN · Entity 4297 | Exercise / conversionCommon Stock | 13,000 | $2.75 | $35,750.00 |
DisclosureSEC source: 0001179110-20-000065 · edgar.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 13,000 shares by means of a cashless exercise. A cashless exercise is a method of exercising a stock option in which the option holder pays the exercise price using shares the reporting person would have received pursuant to the option exercise. As a result of this cashless exercise, the Reporting Person, on a net basis, acquired ownership of an additional 11,001 shares of common stock. Read SEC document |
| December 31, 2019 Filed Jan 6, 2020 19:25 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock Warrant · Derivative | 5,735 | Not disclosed Strike: $0.49 | Not disclosed |
DisclosureSEC source: 0001493152-20-000188 · ownership.xml · derivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,235 Underlying: Common Stock · 5,735 shares Expires 2024-12-31 F1 · price: During the four months ended 12/31/2019, Robert Rudelius accrued $2,166.67 in compensation payable to him. Pursuant to a Board action this $2,166.67 was converted into warrants at a rate of $.47232 and grossed up 125%. Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 21:32 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantRestricted Stock Units · Derivative | 2,591 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-010089 · edgar.xml · derivative · entry 2 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,591 Underlying: Common Stock · 2,591 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. F1 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on September 3, 2019, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units. F1 · derivative.expiration_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on September 3, 2019, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units. Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 21:32 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantStock Option (right to purchase) · Derivative | 10,710 | $0.00 Strike: $15.44 | $0.00 |
DisclosureSEC source: 0001179110-19-010089 · edgar.xml · derivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,710 Underlying: Common Stock · 10,710 shares Expires 2029-09-03 F1 · derivative.exercise_date: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on September 3, 2019, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units. Read SEC document |
| January 15, 2019 Filed Feb 21, 2019 18:01 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock Warrant · Derivative | 87,500 | Not disclosed Strike: $0.30 | Not disclosed |
DisclosureSEC source: 0001493152-19-002344 · ownership.xml · derivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 87,500 shares Expires 2029-01-15 F1 · price: On January 15th, 2019, the Company's Board of Directors approved the issuance of 87,500 warrants for purchase of common stock to Robert Rudelius, vested immediately, for a term of ten years with a strike price of $.30 per share and a one-time protection against a reverse split whereby the strike price will not be adjusted upon combination of outstanding shares of stock; this warrant was issued for increased participation in Company activities above what is expected for a Director of the Board. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 17:09 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | OtherCommon Stock Warrant · Derivative | 10,000 | $20,000.00 Strike: $0.30 | $200,000,000.00 |
DisclosureSEC source: 0001493152-19-000090 · ownership.xml · derivative · entry 9 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Noble Ventures LLC Disclosed balance after: 87,500 Underlying: Common Stock · 10,000 shares Expires 2018-12-31 F4 · derivative.underlying_shares: Pursuant to entering into a Bridge Promissory Note Conversion Agreement, Mr. Rudelius received 10,000 warrants exercisable at $.30 per warrant if exercised on or before December 31, 2018. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 17:09 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock Warrant · Derivative | 10,000 | $20,000.00 Strike: $0.30 | $200,000,000.00 |
DisclosureSEC source: 0001493152-19-000090 · ownership.xml · derivative · entry 8 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Noble Ventures LLC Disclosed balance after: 97,500 Underlying: Common Stock · 10,000 shares Expires 2018-12-31 F4 · derivative.underlying_shares: Pursuant to entering into a Bridge Promissory Note Conversion Agreement, Mr. Rudelius received 10,000 warrants exercisable at $.30 per warrant if exercised on or before December 31, 2018. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 17:09 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | OtherCommon Stock Warrant · Derivative | 10,000 | $20,000.00 Strike: $0.30 | $200,000,000.00 |
DisclosureSEC source: 0001493152-19-000090 · ownership.xml · derivative · entry 7 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Noble Ventures LLC Disclosed balance after: 87,500 Underlying: Common Stock · 10,000 shares Expires 2021-12-31 F2 · derivative.underlying_shares: Pursuant to entering into a Bridge Promissory Note Agreement, Mr. Rudelius received 10,000 warrants exercisable at $.30 per warrant if exercised on or before December 31, 2018. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 17:09 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock Warrant · Derivative | 10,000 | $20,000.00 Strike: $0.30 | $200,000,000.00 |
DisclosureSEC source: 0001493152-19-000090 · ownership.xml · derivative · entry 6 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Noble Ventures LLC Disclosed balance after: 97,500 Underlying: Common Stock · 10,000 shares Expires 2021-12-31 F2 · derivative.underlying_shares: Pursuant to entering into a Bridge Promissory Note Agreement, Mr. Rudelius received 10,000 warrants exercisable at $.30 per warrant if exercised on or before December 31, 2018. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 17:09 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | OtherCommon Stock | 3,333 | $0.30 | $999.90 |
DisclosureSEC source: 0001493152-19-000090 · ownership.xml · nonDerivative · entry 5 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Noble Ventures LLC Disclosed balance after: 591,948 F5 · shares: Pursuant to exercising the warrants mentioned in explanation 4 above, Mr. Rudelius and John Lai entered into a Stock Transfer Agreement whereby John Lai Transferred 3,333 shares of Common Stock to Mr. Rudelius. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.